Can-Fite Updates on its Advanced Liver Cancer Pivotal Phase 3 Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. HOOD
7. DFTX
8. GOOGL
9. MU
10. IBM

Go back to Can-Fite Updates on its Advanced Liver Cancer Pivotal Phase 3 Study
CAN-FITE BIOPHARMA LTD. (NYSE: CANF) Delayed: 3.06 +0.08 (2.68%)
Previous Close $2.98    52 Week High $3.89 
Open $3.06    52 Week Low $1.85 
Day High $3.18    P/E N/A 
Day Low $2.91    EPS $0.00 
Volume 99,984       

CAN-FITE BIOPHARMA LTD. (NYSE: CANF) Delayed: 3.06 +0.08 (2.68%)
Previous Close $2.98    52 Week High $3.89 
Open $3.06    52 Week Low $1.85 
Day High $3.18    P/E N/A 
Day Low $2.91    EPS $0.00 
Volume 99,984